Adaptive Biotechnologies (ADPT) Shares Outstanding (2018 - 2026)

Adaptive Biotechnologies has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $159.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 5.12% year-over-year to $159.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159.7 million (up 5.12% YoY) and the FY2025 annual result came in at $153.8 million, up 4.06% from the prior year.
• Shares Outstanding (Entity) rose to $159.7 million in Q1 2026 per ADPT's latest filing, from $153.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $159.7 million in Q1 2026 and troughed at $142.2 million in Q1 2022.
• A 5-year average of $147.7 million and a median of $147.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) rose 1.21% in 2022, then rose 5.12% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $143.1 million in 2022, then climbed by 1.38% to $145.1 million in 2023, then grew by 1.86% to $147.8 million in 2024, then climbed by 4.06% to $153.8 million in 2025, then climbed by 3.85% to $159.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $159.7 million, $153.8 million, and $152.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.